Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dual Incontinence”

135 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 135 results

Large-scale testing (Phase 3)UnknownNCT02980328
What this trial is testing

Low-level Light Therapy for Overactive Bladder and Urinary Incontinence

Who this might be right for
Overactive BladderUrinary Incontinence
Seoul National University Hospital 120
Post-approval studies (Phase 4)Study completedNCT01018264
What this trial is testing

Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease

Who this might be right for
Overactive Bladder in Parkinson's Disease
University of South Florida 23
Post-approval studies (Phase 4)Study completedNCT00282932
What this trial is testing

Detrol LA In Men With Overactive Bladder.

Who this might be right for
Overactive Bladder (OAB)
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 600
Large-scale testing (Phase 3)Study completedNCT00368706
What this trial is testing

A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients

Who this might be right for
Urinary Bladder, Overactive
Astellas Pharma Inc 246
Large-scale testing (Phase 3)Study completedNCT00912964
What this trial is testing

Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

Who this might be right for
Urinary Bladder, Overactive
Astellas Pharma Inc 2,030
Large-scale testing (Phase 3)Study completedNCT00139724
What this trial is testing

Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet

Who this might be right for
Urinary Incontinence
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 260
Not applicableStudy completedNCT05702567
What this trial is testing

The Effectiveness of Transvaginal Radiofrequency in Women With Stress Urinary Incontinence

Who this might be right for
Urinary Incontinence,StressPelvic Floor DisordersUrinary Incontinence+1 more
José Casaña Granell 42
Post-approval studies (Phase 4)Study completedNCT00137397
What this trial is testing

Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive Bladder

Who this might be right for
Urinary Incontinence
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 80
Post-approval studies (Phase 4)Study completedNCT00333112
What this trial is testing

Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.

Who this might be right for
Urinary Incontinence
Astellas Pharma Inc 398
Early research (Phase 1)Study completedNCT00850590
What this trial is testing

Study of Escalating Doses of NRL001 Given in Slow-release Rectal Suppositories of Different Weights

Who this might be right for
Incontinence
Norgine 48
Large-scale testing (Phase 3)Active Not RecruitingNCT03104517
What this trial is testing

Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence

Who this might be right for
Stress Urinary Incontinence
Cook MyoSite 96
Large-scale testing (Phase 3)Study completedNCT04193176
What this trial is testing

Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042)

Who this might be right for
Chronic Cough
Merck Sharp & Dohme LLC 376
Not applicableUnknownNCT03877640
What this trial is testing

Urinary Stress Incontinence and Urgency in Women With EMSELLA

Who this might be right for
Stress Urinary IncontinenceUrge Incontinence
San Diego Sexual Medicine 21
Not applicableEnded earlyNCT02357784
What this trial is testing

Sacral Neuromodulation in Dual Incontinence: Ultrasound and Afferent Nerve Sensation Assessment

Who this might be right for
Dual IncontinenceFecal IncontinenceUrinary Incontinence+1 more
Northwestern University 1
Testing effectiveness (Phase 2)UnknownNCT00762593
What this trial is testing

Trial Evaluating Transvaginal Electrical Stimulation With a Home Use Programmable Device for Urinary Stress Incontinence

Who this might be right for
Urinary Stress Incontinence
Akontis 150
Large-scale testing (Phase 3)Study completedNCT03583372
What this trial is testing

An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB).

Who this might be right for
Overactive Bladder
Urovant Sciences GmbH 506
Testing effectiveness (Phase 2)Study completedNCT02292628
What this trial is testing

Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence

Who this might be right for
Faecal Incontinence
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud 16
Post-approval studies (Phase 4)Study completedNCT00143377
What this trial is testing

Study to Determine The Effectiveness Of Detrusitol In Patients Diagnosed With OAB

Who this might be right for
Urinary Incontinence
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 600
Not applicableStudy completedNCT05097456
What this trial is testing

Carbon Dioxide Acupulse Laser Treatment Versus Sham Treatment and Stress Urinary Incontinence Symptoms

Who this might be right for
Stress Urinary Incontinence
Rambam Health Care Campus 125
Testing effectiveness (Phase 2)Study completedNCT01340066
What this trial is testing

Safety and Efficacy Study of a New Treatment for Symptoms of Urinary Incontinence

Who this might be right for
Urinary Incontinence
Beech Tree Labs, Inc. 94
Load More Results